Get access to our best features

Get access to our best features

Published 1 year ago

Hopeful glimmers in long war on Alzheimer’s disease

Summary by Ground News

Scientists are buoyed by new findings that could mark a turning point in the field. New drug, called lecanemab, is a monoclonal antibody that targets a protein, amyloid, which clumps into plaques in the brains of people with Alzheimer's. The new drug is expected to win preliminary approval by the Food and Drug Administration next month.

0 Articles

0 Articles

All

Left

Center

Right

The Mercury news

Hopeful glimmers in long war on Alzheimer’s disease

New study builds the foundation for future success against brain decline, reversing decades of disappointment.

1 year ago·San Jose, United States

Read Full Article

Monterey Herald

Hopeful glimmers in long war on Alzheimer’s disease

New study builds the foundation for future success against brain decline, reversing decades of disappointment.

1 year ago·Cherokee County, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left1Leaning Right0Center1Last Updated1 year agoBias Distribution

50% Left, 50% Center

Bias Distribution

50% of the sources lean Left, 50% of the sources are Center

50% Center

The Mercury news

Monterey Herald

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc.